Covid-19 roundup: In­ter­im analy­sis sug­gests Russ­ian vac­cine is 91.6% ef­fec­tive; US inks big deal with Aus­tralian com­pa­ny for its at-home coro­n­avirus test

In­ter­im Phase III da­ta sug­gest Rus­sia’s ade­n­ovirus vac­cine could be ef­fec­tive enough to ri­val mR­NA jabs from Mod­er­na and Pfiz­er.

The Sput­nik V vac­cine had …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER